Paratek Pharmaceuticals
Boston, US · Founded 1996 · 474 employees on LinkedIn
Founders & leadership
EL
Evan LohExecutive
SM
Sean M. JohnstoninExecutive
BA
Beverly ArmstrongExecutive
DM
Dennis MolnarinExecutive
KB
Kathryn BoxmeyerinExecutive
SK
S. Ken TanakaExecutive
MB
Michael BighamExecutive
Board
RL
Richard LimBoard director
Reported raises · per SEC filings
Form D private placements$93M disclosed across 1 round · 2014
▶$93MraisedJul 2014 · 54 investors · PharmaceuticalsRule 506(b)
▶$93MraisedJul 2014 · 54 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Evan LohExecutive Officer, Director
- Sean M. JohnstonExecutive Officer
- Beverly ArmstrongExecutive Officer
- Richard LimDirector
- Dennis MolnarExecutive Officer
- Kathryn BoxmeyerExecutive Officer
- S. Ken TanakaExecutive Officer
- Michael BighamExecutive Officer, Director
- Offering amount
- $93M
- Amount sold
- $93M
- Sales commissions
- $2.5M
- Placement agents
- Trout Capital LLC, Ladenburg Thalmann & Co. Inc.
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Paratek Pharmaceuticals raised?
- Paratek Pharmaceuticals has disclosed $93M raised across 1 round.
- Where is Paratek Pharmaceuticals headquartered?
- Paratek Pharmaceuticals is headquartered in Boston, US.